An open question remains in cancer stem cell (CSC) biology whether CSCs are by definition at the top of the differentiation hierarchy of the tumor. Wilms' tumor (WT), composed of blastema and differentiated renal elements resembling the nephrogenic zone of the developing kidney, is a valuable model for studying this question because early kidney differentiation is well characterized. WT neural cell adhesion molecule 1-positive (NCAM1 + ) aldehyde dehydrogenase 1-positive (ALDH1 + ) CSCs have been recently isolated and shown to harbor early renal progenitor traits. Herein, by generating pure blastema WT xenografts, composed solely of cells expressing the renal developmental markers SIX2 and NCAM1, we surprisingly show that sorted ALDH1 + WT CSCs do not correspond to earliest renal stem cells. Rather, gene expression and proteomic comparative analyses disclose a cell type skewed more toward epithelial differentiation than the bulk of the blastema. Thus, WT CSCs are likely to dedifferentiate to propagate WT blastema.
INTRODUCTION
The cancer stem cell (CSC) model suggests that whereas most tumor cells are destined to differentiate, albeit aberrantly, a small subset of tumor cells, termed CSCs, actively sustain and propagate the tumor. Although CSCs are considered to be at the top of the differentiation hierarchy of the tumor, this has not been examined in human tumors. Wilms' tumor (WT), a prototype of differentiation failure in human cancer, shares the histology of the fetal kidney, including blastema, stroma, and differentiating tubular epithelium (Shukrun et al., 2014; Dekel et al., 2006; Pode-Shakked and Dekel, 2011; Rivera and Haber, 2005) . Because normal renal differentiation is well characterized, WT represents an invaluable model for establishing the position of CSC with respect to this differentiation cascade.
Kidney development is initiated when the Wolffian duct sends off a dorsal branch, the ureteric bud (UB), to invade the metanephric mesenchyme (MM) (Pleniceanu et al., 2010) . The UB receives MM-derived signals to undergo branching morphogenesis and develop into the collecting system. Reciprocally, a fraction of the MM, termed cap mesenchyme (CM), receives signals from the UB tips, facilitating its survival, proliferation, and mesenchymalto-epithelial transition (MET) into nephron epithelia.
Sequential steps during renal MET have been characterized by specific gene expression and signaling pathway activity. This process is accompanied by gradual loss of renal developmental factors and mesenchymal markers (e.g., SIX2, CITED1, and vimentin) and acquisition of epithelial proteins (e.g., E-Cadherin) (Cirio et al., 2014; Metsuyanim et al., 2009; Self et al., 2006) . The CM has been recently shown to consist of true stem cells, capable of self-renewing and differentiating toward different types of nephron epithelia (Cirio et al., 2014; Kobayashi et al., 2008) .
We have recently uncovered the identity of human WT CSCs. WT CSCs were isolated from trilineage WT (composed of blastema, stroma, and tubular epithelium) propagated in mice and characterized by high expression levels of neural cell adhesion molecule 1 (NCAM1) and aldehyde dehydrogenase 1 (ALDH1) enzymatic activity (Pode-Shakked et al., 2013) . These cells possessed both self-renewal and multilineage differentiation capacities, in line with the CSC definition. Immunohistochemical (IHC) analysis of WTs revealed that the CSC population was exclusively localized and scattered within the NCAM1-expressing blastema (Pode-Shakked et al., 2013) . The WT blastema, suggested to resemble the CM harboring multipotent embryonic renal stem cells, is classically regarded as a homogeneous unit. Thus, whereas our analysis demonstrated WT CSCs to overexpress the renal developmental gene set (i.e., SIX2, OSR1, PAX2, and SALL1), compatible with early renal progenitor cells, it was confounded by the presence of mature elements, and the precise developmental phenotype in regard to renal lineage differentiation remained elusive.
Therefore, to pinpoint the exact stage of the WT CSC in respect to embryonic renal stem cell differentiation, highresolution analysis of a pure blastema population is required. Here, we created an in vivo model of pure blastema WT via serial propagation of human WT xenograft (Xn). This allowed us to show that the WT blastema is a heterogeneous-differentiating cell population that follows the renal developmental MET axis. Within this differentiation gradient of WT blastema, we show that WT CSCs are committed epithelial progenitors, and not the earliest mesenchymal renal stem cells, the presumable WT cell of origin (Li et al., 2002) . Hence, WT CSCs must possess both dedifferentiation capacity forming less-differentiated, SIX2-high blastemal cells, as well as epithelial differentiation capability, as previously shown for NCAM1 + ALDH1
+ WT CSCs (Pode-Shakked et al., 2013) . Dedifferentiation of WT CSCs into early mesodermal cells might also explain the presence of heterologous mesodermal elements such as muscle and bone seen in some WTs (Royer-Pokora et al., 2010) .
RESULTS

Generation of Pure Blastema WT Xns
Previous work in our lab demonstrated that whereas WT blastema is lost upon in vitro propagation, generation of WT Xn preserves and even expands the blastema in vivo (Dekel et al., 2006; Metsuyanim et al., 2009) . Here, we show that late-generation (passages 10-15) Xns are composed solely of homogeneous-appearing sheets of blastema cells ( Figure 1A) . Recently, utilizing low-passage WT Xns (passages 1-5), which maintain most of the primary tumor's properties (i.e., gene expression and trilineage histology), we isolated CSCs that exclusively initiate and sustain the tumor in vivo (Dekel et al., 2008 Figure 1C , right panel; Figure S1B ). Late Xn cells were then sorted according to ALDH1 activity with high efficiency as shown via quantitative real-time PCR analysis ( Figure S2A ). 
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The WT CSC Is a Committed Epithelial Progenitor kidney (hFK), (2) US tumors, and (3) CSC-En tumors. First, we performed hierarchical clustering in order to characterize the three samples with respect to the renal developmental signature, as manifested by the expression of several renal developmental genes (i.e., SIX2, SALL1, OSR1, CITED1, and PAX2). The results demonstrated genetic proximity between the two Xn samples, both expressing high levels of the aforementioned genes, compared to hFK, confirming that the pure blastema Xns harbor properties of primitive renal tissue. Interestingly, when comparing the two Xn samples, we found that CSC-En Xns expressed lower levels of the renal developmental genes ( Figure 3C ). We next carried out a quantitative realtime PCR analysis comparing the two Xn samples. This comparison validated the lower expression levels of the renal developmental gene set in the CSC-En sample. Importantly, CSC-En tumors showed higher expression of stemness genes (i.e., NANOG, BMI1, and EZH2), supporting enrichment for WT CSCs ( Figure 3D ). In addition, proteomic analysis supported the gene expression data, demonstrating a relative epithelial phenotype (i.e., high E-Cadherin) of the CSC-En tumors compared to US tumors (Table S1 ). Concomitantly, CSC-En tumors show upregulation of stemness-associated signaling pathways at the protein level (e.g., nuclear factor-kB [NF-kB], Wnt, phosphatidylinositol 3-kinase [PI3K], and mammalian target 
The WT CSC Is a Committed Epithelial Progenitor Figure 4D , left) and higher expression of epithelial markers ( Figure 4D , middle and right). Furthermore, in order to demonstrate in vitro dedifferentiation capacity of the ALDH1 + sorted fraction, cells were grown in culture for 10 days. We observed the acquisition of a mesenchymal phenotype, as manifested by upregulation of vimentin alongside downregulation of ALDH1 expression and the epithelial markers E-Cadherin and EpCAM ( Figure 4E ). Taken together, these results suggest that the WT CSCs are not the least differentiated cells along the renal developmental MET axis but, rather, are arrested at a renal progenitor state, committed to epithelial differentiation. Thus, the WT CSCs are likely to dedifferentiate to propagate WT blastema.
DISCUSSION
Here, by comparing the WT CSCs with normal kidney development, we discover two surprising fundamental concepts. First, in terms of lineage hierarchy, the CSC may not correspond to the earliest normal stem cell but rather to a more differentiated progeny. Second, heterogeneity that mirrors renal stem cell differentiation is present in the homogeneous-appearing WT blastema. Our earlier observations (Pode-Shakked et al., 2013 ) disclosed high similarity between WT CSCs and early renal stem cells. These observations were based on propagation of trilineage human WT, in which the relationship of the CSC to tumor bulk includes a comparison to blastema and also to mature elements, placing the CSC as an undifferentiated renal cell type. Our ability to examine pure blastema Xns enabled (C) Summary of ionizing radiation effect on proliferation and ALDH1 expression of Xn cells. Left view shows that ionizing radiation inhibits cell growth in a dose-and time-dependent manner. Right view shows that exposure of WT Xn cells to ionizing radiation enriches for the ALDH1 + CSC population in a dose-and time-dependent manner. See also Figure S2 . stringent comparison of WT CSCs to the undifferentiated tumor bulk and the unraveling of the findings. Indeed, the importance of the fine-tuning of our system is manifested when comparing WT CSCs to parental tissues (i.e., hFK and pWT), disclosing a relatively undifferentiated phenotype. This precise understanding of the relation between the WT CSC and embryonic renal differentiation affords insights from both oncologic and developmental aspects. Multiple studies have highlighted the relationship between CSCs and their differentiated progeny (Reya et al., 2001) , including WT CSCs, and their ability to generate tubular structures and glomeruloid bodies (Little, 2005; Pode-Shakked and Dekel, 2011; Pode-Shakked et al., 2013) . Nevertheless, the dedifferentiated progeny arising from ALDH1 + WT CSCs, represented by the bulk of the blastema and characterized by higher SIX2 and lower E-Cadherin, illustrates mechanisms for WT and progression. Interestingly, partial reprogramming by pluripotent stemness factors has been recently implicated in generation of a Wilms'-like tumor in vivo (Ohnishi et al., 2014) . Hypothetically, dedifferentiation of WT CSCs may also account for the nonrenal mesenchymal elements observed in WT. This notion is strengthened by the fact that developmental lineages are already specified in the MM, and no common nephron epithelial-stromal progenitor cell has been documented (Brown et al., 2013; Kobayashi et al., 2008; Pleniceanu et al., 2010; Self et al, 2006) . Our work may suggest a revision to the concept that the earliest transformed renal stem cell capable of giving rise to differentiated progeny is the tumor-initiating cell. Alternatively, the WT cell of origin and WT CSCs responsible for tumor propagation may not be the same cell. Resolution of this matter utilizing a transgenic animal model of WT generation that employs specific CRE drivers of renal stem cells (e.g., SIX2) might be complicated because WT CSCs express some levels of SIX2 and WT1. Finally, from the developmental aspect, it remains to be determined how NCAM1 + human nephron progenitors isolated from the hFK and representing more committed epithelial progenitors than uninduced MM (Harari-Steinberg et al., 2013) are relevant for WT once transformed. From a more practical aspect, the unequivocal limitingdilution xenotransplantation data, illustrating ALDH1 + WT CSCs as critical for continued propagation of WT blastema Xns, highlight the WT CSC as a therapeutic target. We previously suggested anti-NCAM1-targeted therapy as a useful means for WT eradication (Pode-Shakked et al., 2013) . Clearly, the NCAM1 expression domain exceeds that of the WT CSC. In this regard, our genomic and proteomic data disclose several specific pathways (e.g., NF-kB, Wnt, PI3K, and mTOR) previously implicated in stemness acquisition (Armstrong et al., 2006; Huang et al., 2012; Katoh and Katoh, 2007; Shostak and Chariot, 2011) as highly operative in WT CSCs. Thus, global analysis not only sheds light on the WT CSC as possessing enhanced stemness alongside a more differentiated renal phenotype but also pinpoints interventions such as mTOR and epidermal growth factor receptor inhibition that may prove beneficial in WT CSC eradication.
EXPERIMENTAL PROCEDURES
Detailed Experimental Procedures are provided in the Supplemental Experimental Procedures.
pWT Samples pWT samples were obtained from patients with WT within 1 hr of surgery from both Sheba Medical Center and Hadassah-EinKerem hospital. All studies were approved by the local ethics committee, . The spheres demonstrated high ALDH1 expression accompanied by high levels of stemness genes (i.e., OCT4, NANOG, TOP2A, and EZH2) along with a more epithelial phenotype (lower levels of SIX2, OSR1, CITED1, and vimentin and higher levels of E-Cadherin and EpCAM). The values for adherent cells were used to normalize (therefore equaling one [1]), and other values were calculated with respect to them. Results are presented as the mean ± SEM of three separate experiments. *p < 0.05; **p < 0.01. See also Figure S2 and Tables S1 and S2. and informed consent was given by the legal guardians of the patients involved according to the Declaration of Helsinki.
In Vivo Xn Formation
The animal experiments were performed in accordance with the Guidelines for Animal Experiments of Sheba Medical Center. Initial WT xenografting to 5-to 8-week-old, female, nonobese diabetic severe combined immunodeficiency (NOD-SCID) mice was performed as previously described (Dekel et al., 2006) . Latepassage Xns were formed by serial injections of approximately 10 6 dissociated cells from freshly retrieved WT Xns. Cells were injected in 100 ml 1:1 serum-free medium/Matrigel (BD Biosciences). See also Supplemental Experimental Procedures.
Statistical Analysis
Results are expressed as the mean ± SEM, unless otherwise indicated. Statistical differences in gene expression between WT cell populations were evaluated using the nonparametric, one-sided sign test. Statistical differences between additional data groups were determined with Student's t test. For all statistical analyses, the level of significance was set as p < 0.05, unless otherwise indicated.
ACCESSION NUMBERS
The GEO accession number for the chromatin immunoprecipitation array data reported in this paper is GSE57269. . ALDH1 + CSCs demonstrate low levels of proliferation-related genes (e.g., PCNA, CCNB1, and E2F1), lower levels of renal developmental genes (e.g., SIX2, OSR1, and CITED1), high levels of stemness genes (e.g., POU5F1, SHH, LIN28A, and KLF4), high expression of epithelial markers (E-Cadherin, Keratin 6c, Keratin 33a, Keratin 35, Claudin 7, Claudin 9, and Claudin 13), and lower levels of mesenchymal markers (vimentin, SNAI2, and MEST). Table S3 .
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